Kurs
+0,96%
Kurs
+0,96%
Open
31,30
High
32,00
Low
31,00
Close
31,70
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
1,43 MNOK
Likviditet
1,43 MNOK
Rel. mcap
0,32%
Antal aktier
45 564
Likviditet under dagen för detta pressmeddelande
Kalender
Tid* | ||
2025-10-28 | 07:00 | Kvartalsrapport 2025-Q3 |
2025-08-14 | 07:00 | Kvartalsrapport 2025-Q2 |
2025-06-04 | N/A | Årsstämma |
2025-04-30 | 07:00 | Kvartalsrapport 2025-Q1 |
2025-02-12 | 18:00 | Bokslutskommuniké 2024 |
2024-10-31 | - | Kvartalsrapport 2024-Q3 |
2024-08-16 | - | Kvartalsrapport 2024-Q2 |
2024-06-05 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
2024-06-04 | - | Årsstämma |
2024-04-30 | - | Kvartalsrapport 2024-Q1 |
2024-02-15 | - | Bokslutskommuniké 2023 |
2023-11-01 | - | Kvartalsrapport 2023-Q3 |
2023-08-11 | - | Kvartalsrapport 2023-Q2 |
2023-06-02 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
2023-06-01 | - | Årsstämma |
2023-05-11 | - | Kvartalsrapport 2023-Q1 |
2023-02-16 | - | Bokslutskommuniké 2022 |
2022-11-01 | - | Kvartalsrapport 2022-Q3 |
2022-08-12 | - | Kvartalsrapport 2022-Q2 |
2022-06-03 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
2022-06-02 | - | Årsstämma |
2022-05-10 | - | Kvartalsrapport 2022-Q1 |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-11-04 | - | Kvartalsrapport 2021-Q3 |
2021-08-13 | - | Kvartalsrapport 2021-Q2 |
2021-06-04 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
2021-06-03 | - | Årsstämma |
2021-05-11 | - | Kvartalsrapport 2021-Q1 |
2021-02-18 | - | Bokslutskommuniké 2020 |
2020-11-06 | - | Kvartalsrapport 2020-Q3 |
2020-08-20 | - | Kvartalsrapport 2020-Q2 |
2020-06-04 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
2020-06-03 | - | Årsstämma |
2020-05-14 | - | Kvartalsrapport 2020-Q1 |
2020-03-11 | - | Extra Bolagsstämma 2020 |
2020-02-13 | - | Bokslutskommuniké 2019 |
2019-11-01 | - | Kvartalsrapport 2019-Q3 |
2019-08-23 | - | Kvartalsrapport 2019-Q2 |
2019-05-29 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
2019-05-28 | - | Årsstämma |
2019-05-15 | - | Kvartalsrapport 2019-Q1 |
2019-02-14 | - | Bokslutskommuniké 2018 |
2018-12-20 | - | Extra Bolagsstämma 2018 |
2018-11-09 | - | Kvartalsrapport 2018-Q3 |
2018-08-24 | - | Kvartalsrapport 2018-Q2 |
2018-06-08 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
2018-06-07 | - | Årsstämma |
2018-05-30 | - | Kvartalsrapport 2018-Q1 |
2018-02-15 | - | Bokslutskommuniké 2017 |
2017-11-10 | - | Kvartalsrapport 2017-Q3 |
2017-07-28 | - | Kvartalsrapport 2017-Q2 |
2017-06-07 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
2017-06-06 | - | Årsstämma |
2017-05-10 | - | Kvartalsrapport 2017-Q1 |
2017-02-15 | - | Bokslutskommuniké 2016 |
2017-01-13 | - | Extra Bolagsstämma 2017 |
2016-11-11 | - | Kvartalsrapport 2016-Q3 |
2016-08-18 | - | Kvartalsrapport 2016-Q2 |
2016-06-21 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
2016-06-20 | - | Årsstämma |
2016-05-11 | - | Kvartalsrapport 2016-Q1 |
2016-02-18 | - | Bokslutskommuniké 2015 |
2015-10-30 | - | Extra Bolagsstämma 2015 |
2015-10-30 | - | Kvartalsrapport 2015-Q3 |
2015-08-21 | - | Kvartalsrapport 2015-Q2 |
2015-06-09 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
2015-06-08 | - | Årsstämma |
2015-04-28 | - | Kvartalsrapport 2015-Q1 |
2015-02-27 | - | Bokslutskommuniké 2014 |
2014-10-31 | - | Kvartalsrapport 2014-Q3 |
2014-08-22 | - | Kvartalsrapport 2014-Q2 |
2014-06-10 | - | Årsstämma |
2014-05-06 | - | Kvartalsrapport 2014-Q1 |
2014-02-27 | - | Bokslutskommuniké 2013 |
2013-11-01 | - | Kvartalsrapport 2013-Q3 |
2013-08-30 | - | Kvartalsrapport 2013-Q2 |
2013-06-13 | - | Kapitalmarknadsdag 2013 |
2013-05-23 | - | Årsstämma |
2013-04-25 | - | Kvartalsrapport 2013-Q1 |
2013-02-15 | - | Bokslutskommuniké 2012 |
2012-02-10 | - | Bokslutskommuniké 2011 |
2011-10-21 | - | Kvartalsrapport 2011-Q3 |
2011-08-25 | - | Kvartalsrapport 2011-Q2 |
2011-05-05 | - | Kvartalsrapport 2011-Q1 |
2011-04-14 | - | Årsstämma |
2011-02-04 | - | Bokslutskommuniké 2010 |
2010-10-28 | - | Kvartalsrapport 2010-Q3 |
2010-08-26 | - | Kvartalsrapport 2010-Q2 |
2010-05-05 | - | Kvartalsrapport 2010-Q1 |
2010-03-25 | - | Årsstämma |
2010-02-11 | - | Bokslutskommuniké 2009 |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
2024-10-07 13:57:07
Oslo, 07 October 2024 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and
reliable provider of high-quality products to hospitals and pharmacies, has
signed joint contracts with Amgros in Denmark, Landspitali Háskólasjúkrahús in
Iceland and Sykehusinnkjøp HF, divisjon legemidler in Norway to be the main
supplier of certain antibiotics to hospital across all three countries. The
contracts start in April 2025 and will run until 2027, with the opportunity for
an extension.
These are the latest of several tenders Navamedic has secured this year,
representing significant growth for the antibiotic's portfolio and predictable
income for the coming years. Together with the recently announced LIS tender,
these represent the largest antibiotics tenders in the Nordics.
"We consider securing this Nordic tender a testament to the quality of our
antibiotic portfolio and our position in the market. Our commitment to
responsible manufacturing of antibiotics has been a cornerstone of our strategy,
and we are proud to see it recognised with this significant tender win," says
Janne Folmoe, Tender Manager at Navamedic ASA.
With new global guidance aimed at reducing antibiotic pollution from
manufacturing, this Nordic tender emphasised the importance of the environment.
Pollution prevention and manufacturing control will play a significant role in
the fight against antimicrobial resistance, and manufacturers and suppliers will
be met with increasingly higher quality criteria. As a member of The AMR
Industry Alliance and with ISO certification, Navamedic has demonstrated that it
is a reliable and responsible supplier of antibiotics.
For further information, please contact:
Kathrine Gamborg Andreassen, CEO, Navamedic
Mobile: +47 951 78 680
E-mail: kathrine@navamedic.com
Lars Hjarrand, CFO, Navamedic
Mobile: +47 917 62 842
E-mail: lars.hjarrand@navamedic.com
Navamedic ASA is a full-service provider of high-quality healthcare products to
hospitals and pharmacies. Navamedic meets the specific medical needs of patients
and consumers by leveraging its highly scalable market access platform, leading
category competence and local knowledge. Navamedic is present in all the Nordic
countries, the Baltics and Benelux, with sales representation in the UK and
Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock
Exchange (ticker: NAVA).
For more information, please visit www.navamedic.com